Sanofi could be months away from wider US approval for Tzield, its first-in-class drug for delaying the progression of type 1 ...

Qatar has set an ambitious target to achieve diabetes control by 2030, launching an aggressive prevention campaign as health ...

The Childhood Diabetes Reduction Act aims to make front-of-pack warning labels mandatory on ultra-processed foods and ...

The Department of Health (DOH) said Monday that among their priorities to address this year is the stunting among children.

Investing.com -- Sanofi announced Monday that the U.S. Food and Drug Administration has accepted a priority review for its Tzield type-1 diabetes drug, potentially expanding its use to children as ...

Semaglutide, the active ingredient in medications like Ozempic and Wegovy, shows promise as a treatment for alcohol addiction ...

The sBLA is supported by 1-year interim data from the ongoing phase 4 PETITE-T1D study, which included 23 children less than 8 years of age with stage 2 T1D.

BENGALURU: Across Bengaluru and several other cities, ophthalmologists reported that there is a steady rise in diabetic ...

The company said the regulator accepted a priority review to potentially expand the current age range for its Tzield type-1 diabetes drug to include children as young as one year old.

Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per ...

It's important to be mindful of many things during pregnancy. Let us explain how ignoring your blood sugar levels during ...

The UK has introduced advertising restrictions to shield children from junk food adverts and improve long-term health ...